About this trial
Meniscopathy surgeries are commonly associated with moderate postoperative pain, particularly during early mobilization and rehabilitation. Inadequate postoperative analgesia may negatively affect functional recovery, delay ambulation, increase opioid consumption, and contribute to opioid-related adverse effects. Therefore, effective multimodal analgesic strategies are of considerable importance in patients undergoing arthroscopic knee procedures.
Adductor canal block (ACB) is a widely used regional anesthesia technique that provides effective analgesia while largely preserving quadriceps muscle strength. However, its limited effect on posterior knee capsule innervation may result in insufficient control of posterior knee pain. Recently, the biceps femoris short head (BiFeS) block has been described as a novel motor-sparing fascial plane block targeting the posterolateral knee capsule and may provide additional analgesic benefit when combined with ACB.
In this study, it was aimed to compare the postoperative analgesic efficacy of adductor canal block alone and adductor canal block combined with BiFeS block in patients undergoing surgery for meniscopathy.
Eligibility criteria
Qualifiers
Patients aged 18-65 years
American Society of Anesthesiologists (ASA) score I-II-III
Body Mass Index (BMI) between 18-30 kg/m2
Disqualifiers
Patients under 18 and over 65 years of age
ASA score IV and above
Patients with a history of bleeding diathesis
BMI below 18 or above 30 kg/m2
Trial design
Treatments tested in this trial
- Adductor Canal Block Group
- Adductor Canal Block + BiFeS (Biceps Femoris Short Head) Block Group
- Control Group